Proteomic Biomarkers and Pathway Analysis for Progression to Heart Failure in Three Epidemiological Representative Cohorts
In conclusion, our study reinforces the role of NT-proBNP as a key biomarker for asymptomatic cardiac dysfunction and incident HF, consistent with its established use in clinical practice. This underscores the value of NT-proBNP for identifying patients at high risk for HF, and provides insights into pathways leading to HF and potential therapeutic targets.
Authors
- Arantxa González (ORCID: https://orcid.org/0000-0001-5986-6528)
- Petri Gudmundsson (ORCID: https://orcid.org/0000-0002-2863-1141)
- Anna Dieden (ORCID: https://orcid.org/0000-0002-1041-937X)
- Nicolas Girerd (ORCID: https://orcid.org/0000-0002-3278-2057)
- Amra Jujić (ORCID: https://orcid.org/0000-0002-9506-0158)
- John G.F. Cleland (ORCID: https://orcid.org/0000-0002-1471-7016)
- Zohra Lamiral (ORCID: https://orcid.org/0000-0001-7349-7124)
- Martin Magnusson (ORCID: https://orcid.org/0000-0003-1710-5936)
- Kévin Duarte (ORCID: https://orcid.org/0000-0002-0292-0498)
- John Molvin (ORCID: https://orcid.org/0000-0003-2107-0510)
- Margrét Leósdóttir (ORCID: https://orcid.org/0000-0003-1677-1566)
- Erasmus Bachus (ORCID: https://orcid.org/0000-0001-8665-6892)
- Manan Pareek (ORCID: https://orcid.org/0000-0002-0867-5825)
- Michael Hecht Olsen (ORCID: https://orcid.org/0000-0003-2230-5780)
- Filip Ottosson (ORCID: https://orcid.org/0000-0002-8312-3545)
- Patrick Rossignol (ORCID: https://orcid.org/0000-0003-4470-7932)
- Olle Melander (ORCID: https://orcid.org/0000-0002-2581-484X)
- Ulf Lindblad
- Bledar Daka (ORCID: https://orcid.org/0000-0002-7722-1528)
- Christian Delles
- Andrew L. Clark (ORCID: https://orcid.org/0000-0002-5213-9624)
- Lennart Råstam
- Faïez Zannad
- P.M. Nilsson
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- National Academy of Medicine (US)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Malmö University (SE)
- Lund University (SE)
- North-West University (ZA)
- Princess Grace Hospital Centre (MC)
- Castle Hill Hospital (GB)
- Instituto de Salud Carlos III (ES)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- British Heart Foundation (GB)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Navarre Institute of Health Research (ES)
- Clinica Universidad de Navarra (ES)
- Skåne University Hospital (SE)
- Holbæk Sygehus (DK)
- French Clinical Research Infrastructure Network (FR)
- University of Glasgow (GB)
- University of Gothenburg (SE)
- Universidad de Navarra (ES)
- Université de Lorraine (FR)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1002/ejhf.3502
- Citations
- 3
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- Merck KGaA
- Aase og Ejnar Danielsens Fond
- Lunds Universitet
- Hjärt-Lungfonden
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Ernhold Lundströms stiftelse
- Hulda och E Conrad Mossfelts Stiftelse för Vetenskaplig Forskning Inom Hjärt- och Kärlsjukdomarnas Område
- Region Skåne
- Skånes universitetssjukhus
- Medicinska Fakulteten, Lunds Universitet